Product NDC: | 17478-419 |
Proprietary Name: | Chlorothiazide Sodium |
Non Proprietary Name: | Chlorothiazide Sodium |
Active Ingredient(s): | 500 mg/1 & nbsp; Chlorothiazide Sodium |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 17478-419 |
Labeler Name: | Akorn, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA011145 |
Marketing Category: | NDA AUTHORIZED GENERIC |
Start Marketing Date: | 20120813 |
Package NDC: | 17478-419-40 |
Package Description: | 1 VIAL in 1 CARTON (17478-419-40) > 1 INJECTION in 1 VIAL |
NDC Code | 17478-419-40 |
Proprietary Name | Chlorothiazide Sodium |
Package Description | 1 VIAL in 1 CARTON (17478-419-40) > 1 INJECTION in 1 VIAL |
Product NDC | 17478-419 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Chlorothiazide Sodium |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120813 |
Marketing Category Name | NDA AUTHORIZED GENERIC |
Labeler Name | Akorn, Inc. |
Substance Name | CHLOROTHIAZIDE SODIUM |
Strength Number | 500 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |